Bopei Cui

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Medical Products Administration, Hebei University of Chinese Medicine, National Institutes for Food and Drug Control

发表论文 21 篇 · 总被引 307 次 · h-index 8

代表论文

Boosting with heterologous vaccines effectively improves protective immune responses of the inactivated SARS-CoV-2 vaccine (2021 · Emerging Microbes & Infections · 被引 105)
Safety and immunogenicity of a recombinant COVID-19 vaccine (Sf9 cells) in healthy population aged 18 years or older: two single-center, randomised, double-blind, placebo-controlled, phase 1 and phase 2 trials (2021 · Signal Transduction and Targeted Therapy · 被引 36)
COVID-19 vaccines: progress and understanding on quality control and evaluation (2021 · Signal Transduction and Targeted Therapy · 被引 30)
Non-small cell lung cancers (NSCLCs) oncolysis using coxsackievirus B5 and synergistic DNA-damage response inhibitors (2023 · Signal Transduction and Targeted Therapy · 被引 20)
A neonatal mouse model of central nervous system infections caused by Coxsackievirus B5 (2018 · Emerging Microbes & Infections · 被引 19)
A potential therapeutic neutralization monoclonal antibody specifically against multi-coxsackievirus A16 strains challenge (2019 · Human Vaccines & Immunotherapeutics · 被引 18)